Table 1. Baseline patient characteristics.
Characteristic | |
---|---|
Age, years | |
Median | 62 |
Range | 38–80 |
Sex, number (%) | |
Male | 14 (56%) |
Female | 11 (44%) |
Race, number (%) | |
White | 19 (76%) |
Black | 3 (12%) |
Asian | 1 (4%) |
Unknown or other | 2 (8%) |
Previous chemotherapy regimens for advanced disease, number | |
Median | 2 |
Range | 1–7 |
Prior radiation therapy for cholangiocarcinoma, number (%) | 11 (44%) |
Treatment site, number (%) | |
MD Anderson Cancer Center | 18 (72%) |
Johns Hopkins University | 7 (28%) |
ECOG performance status, number (%) | |
0 | 10 (40%) |
1 | 15 (60%) |
Cholangiocarcinoma subtype, number (%) | |
Intrahepatic | 5 (20%) |
Perihilar or distal | 20 (80%) |
Abbreviation: ECOG=Eastern Cooperative Oncology Group.